alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED
PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael E. Lehman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Sun Microsystems, Inc. on Form 10-Q for
the period ended December 30, 2007 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material
respects the financial condition and results of operations of Sun Microsystems, Inc.



|                       |  |        |  |                        
|---------------------- |  | ------ |  | -----------------------
|Date: February 4, 2008 |  | By:    |  | /s/ MICHAEL E. LEHMAN  
|                       |  | Name:  |  | Michael E. Lehman      
|                       |  | Title: |  | Chief Financial Officer
Robert W. KRAMER, Petitioner, v. STATE of Florida, Respondent.

No. 1D18-2489

District Court of Appeal of Florida, First District.

August 1, 2019

Robert David Malove of the Law Office of Robert David Malove, P.A., Fort Lauderdale, for Peitioner.

Ashley Moody, Attorney General, and Heather Ross, Assistant Attorney General, Tallahassee, for Respondent.

Per Curiam.

DENIED.

Makar, Winokur, and M.K. Thomas, JJ., concur.
FDA Office of Women’s Health

www.fda.gov/womensdiabetes

Your 

Glucose Meter

Glucose meters test and record how much 

sugar (called glucose) is in your blood. They 

help you track your blood sugar level at 

different times of the day and night.

Meters can help you know how well your 

diabetes medicines are working.

They can also help teach you how the food 

you eat and exercise can change your blood 

sugar level.

Meters come in different sizes. 

Meters also come with different 

features. Some meters let you 

track and print out your test results. 

Others have audio and larger 

screens to help people who have 

problems seeing. The meter you 

choose should fit your lifestyle 

and your needs.

Three things you will 

need with your meter:

• Lancet — A small needle used to get a drop 

of blood from your finger or other part of 

your body.

• Test Strip — The strip goes in the meter. 

You put a drop of blood on the strip.

• Control Solution — Liquid used to make 

sure your meter is working right. 
1. Read the directions for your 

meter and test strips before 

you use them.

2. Wash your hands before

you check your blood sugar. 

Food or juice on your 

fingers could make the 

meter give you the wrong 

result.

3. Use the right test strip for 

your meter. 

The meter may not work 

right or may give you the 

wrong result if you use the 

wrong test strip.

4. Write down your results 

and the date and time 

you tested. 

Do this even if your meter 

tracks your numbers. Take 

the results with you when 

you go to your doctor.

5. Clean your meter as directed. 

Some cleaning products may 

harm your meter.

6. Ask your healthcare provider 

if your medicines will change 

your blood sugar. 

If you are a kidney patient on 

dialysis, the dialysis solution 

can change your blood 

sugar.

7. Take your meter with you 

when you go to your doctor. 

This way you can test your 

blood sugar in front of the 

doctor or nurse to make 

sure you are doing it the 

right way. Your healthcare 

provider may be able to 

print out your blood sugar 

results from your meter.

 This fact sheet was developed by the FDA Office of Women’s Health.

To get other FDA diabetes resources, go to: 

www.fda.gov/womensdiabetes

2018

7 Helpful Tips For Testing Your Blood Sugar
Brian A. HALLMAN, Appellant, v. STATE of Florida, Appellee.

Nos. 1D18-4070 1D18-4071 1D18-4072 1D18-4073

District Court of Appeal of Florida, First District.

July 23, 2019

Lucas J. Taylor of Sellers, Taylor & Morrison, P.A., Live Oak, for Appellant.

Ashley Moody, Attorney General, and Quentin Humphrey, Assistant Attorney General, Tallahassee, for Appellee.

Per Curiam.

Appellant, Brian A. Hallman, appeals four revocation orders in which the trial court found that he violated probation by committing the new law offense of dealing in stolen property.* Appellant argues, and the State concedes, that the revocation was improperly based solely on hearsay evidence. Because we agree with Appellant and accept the State's concession, we reverse Appellant's revocation and remand with instructions that his probation be reinstated. *See**Melton v. State* , 65 So. 3d 96, 97 (Fla. 1st DCA 2011) ("While hearsay is admissible at a probation revocation hearing, a revocation of probation may not be based solely upon hearsay evidence, and where the state seeks to revoke probation based on a violation ... by the commission of a new offense, it is required to present direct, non-hearsay evidence linking the defendant to the commission of the offense."); *see also**Johnson v. State* , 962 So. 2d 394, 397-98 (Fla. 2d DCA 2007) (reversing a revocation order where the only evidence linking the appellant to the stolen items was hearsay); *J.F. v. State* , 889 So. 2d 130, 131 (Fla. 4th DCA 2004) (reversing the revocation order where the only proof of possession of the stolen property by the appellant was based upon hearsay).

REVERSED and REMANDED with directions.

Lewis, Makar, and Bilbrey, JJ., concur.

*

We have consolidated Appellant's four appeals for purposes of this opinion.
In the Matter of Disbarment of David Alan FRIEDMAN.

No. D-2708.

Supreme Court of the United States

May 28, 2013.

Disbarment order entered.
George C. PUGH, Appellant, v. STATE of Florida, Appellee.

No. 1D18-523

District Court of Appeal of Florida, First District.

June 4, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
### PD-0811-15 COURT OF CRIMINAL APPEALS

AUSTIN, TEXAS Transmitted 7/17/2015 3:43:03 PM Accepted 7/21/2015 9:14:26 AM

ABEL ACOSTA CLERK
N O T FO R PUB L ICAT IO N UNITED STATES C OUR T OF APPEALS FOR THE NINTH C IR C UIT UNITED STATES OF AM ER IC A,

Pla i ntiff-Appe lle e , v. POLOTANI LATU, a .k.a . P, a .k.a . Pa ul, De fe nda nt-Appe l la

nt. No. 16-10032

D.C . No. 1:02-c r-00174-HG M EM O R ANDUM *

Appe a l from

the Unite d

Stat e s Distric t C ourt for the Distric t of Ha

wa ii He le n W . Gillm or, Distric t Judge , Pre siding Subm itte d De c e m

be r 14, 2016 ** B e fore : WALLAC E, LEAVY, a nd FISHER , C irc uit Judge s. Polota ni La tu a ppe a ls pro se from

the distric t c ourt’ s orde r de ny ing his m otion for a

se nte nc e re duc tion unde r 18 U.S.C . § 3582(c )(2). W e have jurisdic tion unde r 28 U.S.C . § 1291, a nd we a ffirm . 

# FIL ED DEC 19 2016 M OLLY C. DW Y ER, CLERK U . S. CO URT O F APPEALS

* This disposition is not a ppropria te for public at ion a

nd is not pre c e de nt e xc e pt a s provide d

by Ninth C irc uit R

ule 36-3.

* * The pa

ne l una nim ously c onc lude s this c a se is suita ble for de c ision without oral a

rgum e nt. Se e Fe d. R . App. P. 34(a)(2).Latu c onte nds tha t he is e ntitle d to a

se nte n c e re duc tion unde r Am e ndm e nt 782 to theSe nte nc ing Guide line s. W e re vie w de novo whe the r a distric t c o urt ha d a uthority to m odify

a se nte nc e unde r se c tion 3582(c )(2). Se eUnite d State s v . Syk e s , 658 F.3d 1140, 1144 (9th C ir. 2011). La tu’ s 240-m onth se nte nc e re fle c ts the m andatory

m inim um for his offe nse . Se e21 U.S.C . § 848(a ). The m andatory m inim um a pplie s in se c tion 3582(c )(2) proc e e dings. Se eSyk e s , 658 F.3d a

t 1147- 48. Thus, the

distric t c ourt c orre c tly

c onc lude d tha

t it ha d no a uthority to re duc e Latu’ s se nte nc e be low 240 m onths. Se eid . at 1148. To the e xte nt La

tu c onte nds tha

t he would not be

c ha rge d with a

c rim e c arry ing a m andatory

m inim um se nte nc e unde r c urre nt De pa rtm e nt of Justic e disc re tiona

ry polic y , his c la i m

is not c ogniz a

b le in a se c tion 3582(c )(2) proc e e ding. Se e Dillon v . Unite d State s , 560 U.S. 817, 826 (2010). AFFIRM E D.

1 6 - 1 0 0 3 2 2
EXHIBIT 32 
Section 1350 Certifications  STATEMENT FURNISHED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned are the Chief Executive Officer and Principal Financial Officer of Vision Industries Corp. This Certification is made pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This Certification accompanies the Annual Report on Form 10-K of Vision Industries Corp. for the year ended December 31, 2009. The undersigned certify that such 10-K Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such  Amended 10-K Report fairly presents, in all material respects, the financial condition and results of operations of Vision Industries Corp. as of December 31, 2009. This Certification is executed as of March 26, 2010. By:/s/ MARTIN SCHUERMANNMartin Schuermann
President and Chief Executive Officer 
(Principal Executive Officer)  By:/s/ LAWRENCE WEISDORNLawrence Weisdorn
Chief Financial Officer 
(Principal Financial Officer)  A signed original of this written statement required by Section 906 has been provided to Vision Industries Corp. and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

KATHLEEN DAVIS,

Plaintiff,

v.

PFIZER INC, et al.,

Defendants.

Case No. 14-cv-01204-SI 

SUA SPONTE JUDICIAL REFERRAL 

FOR PURPOSES OF DETERMINING 

RELATIONSHIP OF CASES

Pursuant to Civil Local Rule 3-12(c), the Court sua sponte refers this case to the Honorable 

Edward M. Chen to determine whether it is related to Little v. Pfizer Inc., 14-cv-01177-EMC.

IT IS SO ORDERED.

Dated: March 14, 2017

______________________________________

SUSAN ILLSTON

United States District Judge

Case 3:14-cv-01204-EMC Document 116 Filed 03/14/17 Page 1 of 1
Samuel Patrick PETERSON, Appellant, v. STATE of Florida, Appellee.

No. 1D18-3994

District Court of Appeal of Florida, First District.

June 17, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
STATE of Louisiana v. Eugene SHORT

NO. 2019-KK-0381

Supreme Court of Louisiana.

June 17, 2019

*1259Denied.

JOHNSON, C.J., would grant.

HUGHES, J., would grant.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

LACY ROSE,

Plaintiff,

v.

EQUIFAX, INC., et al.,

Defendants.

Case No. 17-cv-00419-MMC 

ORDER RE: STIPULATIONS

Re: Dkt. Nos. 18, 19

On February 16, 2017, and February 17, 2017, respectively, plaintiff Lacy Rose 

entered stipulations with defendants Equifax, Inc. and TD Bank, USA National 

Association (“Stipulating Defendants”), by which the parties agreed to extend the time for 

Stipulating Defendants’ responses to plaintiff’s complaint and also, in the event such 

response is a motion to dismiss, to expand the briefing schedule thereon. 

To the extent the parties have agreed upon an extension of time to respond to 

plaintiff’s complaint, such stipulation is effective “without a Court order.” See Civil L.R. 6-

1(a). 

To the extent the parties wish to alter the briefing schedule, however, the parties 

are hereby advised that they will need to obtain court approval. See Civil L.R. 6-1(b) 

(providing “[a] Court order is required” for “any enlargement or shortening of time that 

alters an event or deadline . . . that involves papers required to be filed or lodged with the 

Court (other than an initial response to the complaint)”).

IT IS SO ORDERED.

Dated: February 23, 2017

MAXINE M. CHESNEY

United States District Judge

Case 3:17-cv-00419-MMC Document 22 Filed 02/23/17 Page 1 of 1
Exhibit 35

- Filed Under Seal -

Case 5:17-cv-00551-LHK Document 285-36 Filed 10/18/18 Page 1 of 1
| (1)   | the      annual Report on Form 10-K of Bold View Resources, Inc. for the year ended      May 31, 2008 fully complies with the requirements of Section 13(a) or      15(d) of the Securities Exchange Act of 1934;  and |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | the      information contained in the annual Report on Form 10-K for the year ended      May 31, 2008, fairly presents in all material respects, the financial      condition and results of operations of Bold View Resources,      Inc. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  By:    |  /s/      Richard Howie                                                         |
|--------------|--------------------------------------------------------------------------------------|
|  Name:  |  Richard      Howie                                                             |
|  Title: |  Principal      Executive Officer,Principal      Financial Officer and Director |
|  Date:  |  August      18, 2008                                                           |
Exhibit 32.1

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, John J.
Quicke, certify to the best of my knowledge based upon a review of the Quarterly Report on Form 10-Q of ADPT Corporation for the quarter ended October 1, 2010 (the Form 10-Q), that the Form 10-Q fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of
operations of ADPT Corporation for the quarterly periods covered by the Form 10-Q.



|                       |  |  |  |                                               
|---------------------- |  |  |  | ----------------------------------------------
|                       |  |  |  | By: /s/ JOHN J. QUICKE                        
|Date: November 5, 2010 |  |  |  | John J. Quicke Interim
Chief Executive Officer

I, Mary L. Dotz, certify to the best of my knowledge based upon a review of the
Form 10-Q, that the Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of ADPT Corporation for the periods covered by the Form 10-Q.



|                       |  |  |  |                                     
|---------------------- |  |  |  | ------------------------------------
|                       |  |  |  | By: /s/ MARY L. DOTZ                
|Date: November 5, 2010 |  |  |  | Mary L. Dotz Chief
Financial Officer
[Federal Register Volume 60, Number 82 (Friday, April 28, 1995)]
[Notices]
[Page 21024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10492]



-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY
Fiscal Service


Treasury Current Value of Funds Rate

AGENCY: Financial Management Service, Fiscal Service, Treasury.

ACTION: Notice of revised rate for use in Federal debt collection and 
discount evaluation.

-----------------------------------------------------------------------

SUMMARY: Pursuant to Section 11 of the Debt Collection Act of 1982 (31 
U.S.C. 3717), the Secretary of the Treasury is responsible for 
computing and publishing the percentage rate to be used in assessing 
interest charges for outstanding debts on claims owed the Government. 
Treasury's Cash Management Regulations (I TFM 6-8000) also prescribe 
use of this rate by agencies as a comparison point in evaluating the 
cost-effectiveness of a cash discount. Notice is hereby given that the 
applicable rate is 5 percent for the second half of calendar year 1995.

DATES: The rate will be in effect for the period beginning on July 1, 
1995 and ending on December 31, 1995.

FOR FURTHER INFORMATION CONTACT:
Inquiries should be directed to the Program Compliance & Evaluation 
Division, Financial Management Service, Department of the Treasury, 401 
14th Street, S.W., Washington, D.C. 20227 (Telephone: (202) 874-6630).

SUPPLEMENTARY INFORMATION: The rate reflects the current value of funds 
to the Treasury for use in connection with Federal Cash Management 
systems and is based on investment rates set for purposes of Pub. L. 
95-147, 91 Stat. 1227. Computed each year by averaging investment rates 
for the 12-month period ending every September 30 for applicability 
effective January 1, the rate is subject to quarterly revisions if the 
annual average, on the moving basis, changes by 2 per centum. The rate 
in effect for the second half of calendar year 1995 reflects the 
average investment rates for the 12-month period ended March 31, 1995.

    Dated: April 14, 1995.
Larry D. Stout,
Assistant Commissioner, Federal Finance.
[FR Doc. 95-10492 Filed 4-27-95; 8:45 am]
BILLING CODE 4810-35-M
Charles L. RYAN, Director, Arizona Department of Corrections, petitioner, v. Joe Leonard LAMBRIGHT.

No. 12-1190.

Supreme Court of the United States

June 3, 2013.

Motion of respondent for leave to proceed *in forma pauperis* granted. Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
|   | (1) | Such Annual Report on Form 10-K/A for the year ended December 31, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in such Annual Report on Form 10-K/A for the year ended December 31, 2012, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                   |   |                                                       |   |
|------------------------|--------|------------------------------------------------------------|--------|
| Date: May 8, 2013 | By:    | /s/ Burt Hodges                                            |   |
|                   |   | Burt Hodges                                                |   |
|                   |   | Principal Financial OfficerRevolutions Medical Corporation |   |
Exhibit 31.1

                                  CERTIFICATION

I, Alfred S. Whittet, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Wilber Corporation;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report.

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report.

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

      a) Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the registrant, including
      its consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this quarterly report is
      being prepared;

      b) Evaluated the effectiveness of the registrant's disclosure controls and
      procedures as of the end of the period covered by this report based on
      such evaluation ( the "Evaluation Date"); and

      c) Disclosed in this quarterly report any change in the registrant's
      internal control over financial reporting that occurred during the
      registrant's first fiscal quarter that has materially affected, or is
      reasonably likely to affect the registrant's internal control over
      financial reporting.

Date: May 7, 2004


By: /s/ Alfred S. Whittet
   ----------------------------------
President and Chief Executive Officer


                                       21
Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Organization Charts

FDA Organization Charts Home
          About FDA
          FDA Organization
          FDA Organization Charts
          Office of Operations Organization ChartFDA Organization Charts Office of Operations Organization Chart
  
  	
    Share
    Post
    Linkedin

    Email
    PrintOO Leadership 2021 10 04
Text version of the above chart | Printer-friendly Version (PDF - 65KB)

Return to FDA Organization Charts

                                                                                  Content current as of:
      09/28/2022FDA Organization Charts
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop